Brand Finance identifies PepsiCo as the global food company most vulnerable to GLP-1 weight-loss drugs like Ozempic.
The report highlights Lay's as the world's most exposed food brand. Lay's faces a potential $6.8 billion loss in brand value.
Five major PepsiCo snack brands, including Doritos and Cheetos, face a combined $14.1 billion exposure. GLP-1 medications cause users to reduce consumption of calorie-dense snacks and sugary drinks.
The report estimates that GLP-1 drugs put $73 billion in total value at risk for the world's top 100 food brands.